Publications
Specialty
Search
Psych Congress Network
10/03/2024
High-dose psilocybin demonstrated an effect similar to escitalopram for the treatment of depressive symptoms in a recent systematic review and meta-analysis published in The BMJ.
EP Lab Digest
10/03/2024
Featured is the presentation entitled "Potential Role of Device-Based Electrical Therapies in AF With HF" by Stavros Stavrakis, MD, PhD, at the 2024 Western AF Symposium.
EP Lab Digest
10/02/2024
New UCLA-led research highlights the important role that these guidelines can play in reducing mortality rates for individuals suffering from heart failure with reduced ejection fraction (HFrEF), a type of heart failure affecting an estimated 29 million people worldwide.
Oncology
10/02/2024
Fred Saad, MD, discusses results from the phase 3 ARANOTE trial which assessed the efficacy and tolerability of adding darolutamide to androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.
Wounds
10/02/2024
Pharmacy Learning Network
10/02/2024
AbbVie Inc. is recalling more than 3 million tubes of Refresh PM and Refresh Lacri-Lube lubricant eye ointment due to a lack of assurance of sterility.
Pharmacy Learning Network
10/02/2024
Ascend Laboratories is recalling 117 493 bottles of mycophenolic acid delayed-release tablets after samples failed to meet dissolution specifications.
Pharmacy Learning Network
10/02/2024
More than 2 million tubes of mupirocin ointment distributed by Glenmark Pharmaceuticals are under recall for subpotency.
Journal of Clinical Pathways
10/02/2024
Uncover the latest breakthroughs in prognostic models for myelofibrosis, highlighting how advancements in genetic understanding and artificial intelligence are revolutionizing treatment decisions and personalizing care for better patient outcomes.
Oncology
10/02/2024
According to a prospective phase 2 trial, a high IPSS risk score, high baseline fetal hemoglobin level, and sustained declines in circulating CD34+ cell counts were associated with response to hypomethylating agent decitabine treatment for patients with myelofibrosis.
Journal of Clinical Pathways
10/02/2024
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including critical issues in the health care system, emphasizing the need for innovative solutions to improve accessibility, affordability, and quality of care.
Vascular Disease Management, Cath Lab Digest, Journal of Invasive Cardiology
10/02/2024
The Pounce XL Thrombectomy System is indicated for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature in vessels 5.5–10 mm in diameter, making it suitable for iliac, femoral, and other arteries within this range.
Wounds
10/02/2024
This lecture summary provides an overview of a few key pieces of information to better understand NPWT from the recent hands-on preconference workshop at SAWC Fall, An Algorithmic Approach to Negative Pressure Wound Therapy: A Hands-On Skills Lab, supported by an educational grant from Solventum, Medical Surgical Business.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/02/2024
“There are significant regional disparities that exist across the world, and this study draws attention to the fact that heart failure is not a monolithic entity, but a condition that varies greatly based on socioeconomic and cultural nuances,” said Dr. Gregg Fonarow.
First Report Managed Care
10/02/2024
Discover how the addition of daratumumab to standard treatment improves outcomes for patients with high-risk cytogenetic abnormalities in multiple myeloma according to a SOHO 2024 presenter.
Oncology
10/02/2024
The phase 3 SAKK 41/13 trial provides the first prospective data that there is a protective effect with adjuvant advil among patients with resected, PIK3CA-mutant colon cancer.
Oncology
10/02/2024
Luspatercept provides a new standard of care for erythropoiesis-stimulating agent-naïve patients with transfusion-dependent, lower-risk myelodysplastic syndromes, determined primary analysis results from the phase 3 COMMANDS study.
First Report Managed Care, Population Health
10/02/2024
Navigating the murky waters of Senate procedures, including the filibuster, is crucial for understanding why health care reform proposals struggle to become reality in the US.
Gastroenterology
10/02/2024
Declines in colorectal cancer screening rates between 2019 and 2020 were most dramatic in health centers that serve mostly Hispanic/Latino and unhoused patients.
Oncology
10/01/2024
According to interim analysis results from a phase 2 study, the addition of BMS-986012, a novel IgG1 monoclonal antibody, to carboplatin plus etoposide and nivolumab demonstrated promising efficacy and safety as first-line treatment for patients with extensive-stage small cell lung cancer.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
